buprenorphine 300 MG per 1.5 ML Prefilled Syringe

RxCUI: 1996192
RxNorm name: buprenorphine 300 MG per 1.5 ML Prefilled Syringe
Display name: buprenorphine 300 MG per 1.5 ML Prefilled Syringe
Full name: buprenorphine 300 MG per 1.5 ML Prefilled Syringe
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SUBLOCADE	BUPRENORPHINE	Indivior Inc.	6189fb21-9432-45f8-8481-0bfaf3ccde95	2026-07-27	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1996192

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6189fb21-9432-45f8-8481-0bfaf3ccde95	buprenorphine 300 MG per 1.5 ML Prefilled Syringe	SY	42	These highlights do not include all the information needed to use SUBLOCADE ® safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 2002	20251222
6189fb21-9432-45f8-8481-0bfaf3ccde95	buprenorphine 300 MG in 1.5 mL Prefilled Syringe	PSN	42	These highlights do not include all the information needed to use SUBLOCADE ® safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 2002	20251222
6189fb21-9432-45f8-8481-0bfaf3ccde95	1.5 ML buprenorphine 200 MG/ML Prefilled Syringe	SCD	42	These highlights do not include all the information needed to use SUBLOCADE ® safely and effectively. See full prescribing information for SUBLOCADE. SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use, CIII Initial U.S. Approval: 2002	20251222